EWM
FRTX

Elmwood Wealth Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Elmwood Wealth Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-73
Closed -$1K – 349
2021
Q4 		$1K Buy
+73
New +$1.31K ﹤0.01% 365
2021
Q2 		$3K Hold
73
– – ﹤0.01% 299
2021
Q1 		$4K Buy
+73
New +$4.01K ﹤0.01% 280

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return

Elmwood Wealth Management's FRTX Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2022, closing a stake of 73 shares — an estimated $1K sold.

Elmwood Wealth Management first reported a position in FRTX in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q1 2021. 22 funds tracked by Wall St. Rank hold FRTX as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 73 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Elmwood Wealth Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Elmwood Wealth Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $4K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.